BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16570912)

  • 1. Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity.
    Wang EY; Gao H; Salter-Cid L; Zhang J; Huang L; Podar EM; Miller A; Zhao J; O'rourke A; Linnik MD
    J Med Chem; 2006 Apr; 49(7):2166-73. PubMed ID: 16570912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
    O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
    J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
    Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
    J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tissue-bound semicarbazide-sensitive amine oxidase by two haloamines, 2-bromoethylamine and 3-bromopropylamine.
    Kinemuchi H; Kobayashi N; Takahashi K; Takayanagi K; Arai Y; Tadano T; Kisara K; Oreland L
    Arch Biochem Biophys; 2001 Jan; 385(1):154-61. PubMed ID: 11361012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1).
    Foot JS; Deodhar M; Turner CI; Yin P; van Dam EM; Silva DG; Olivieri A; Holt A; McDonald IA
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3935-40. PubMed ID: 22595173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
    Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
    Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase and semicarbazide sensitive amine oxidase activities in normal and inflamed human dental pulp.
    Vavilova T; Ostrovskaya I; Axenova L; Buneeva O; Medvedev A
    Med Sci Monit; 2009 Oct; 15(10):BR289-292. PubMed ID: 19789505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis.
    O'Rourke AM; Wang EY; Salter-Cid L; Huang L; Miller A; Podar E; Gao HF; Jones DS; Linnik MD
    J Neural Transm (Vienna); 2007; 114(6):845-9. PubMed ID: 17393060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Various mammalian tissues contain cell membrane-bound amine oxidase termed semicarbazide-sensitive amine oxidase (SSAO, EC 1.4.3.6)].
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):88P-90P. PubMed ID: 12491790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.
    Langford SD; Trent MB; Balakumaran A; Boor PJ
    Toxicol Appl Pharmacol; 1999 Mar; 155(3):237-44. PubMed ID: 10079209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSAO inhibitors suppress hepatocellular tumor growth in mice.
    Li R; Li H; Luo HJ; Lin ZX; Jiang ZW; Luo WH
    Cell Immunol; 2013; 283(1-2):61-9. PubMed ID: 23850964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of tissue-bound semicarbazide-sensitive amine oxidase activity in carp tissues.
    Takahashi K; Kakuta I; Sugimoto H; Obata T; Oreland L; Kinemuchi H
    Life Sci; 2007 Feb; 80(12):1094-9. PubMed ID: 17215008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivo.
    Foot JS; Yow TT; Schilter H; Buson A; Deodhar M; Findlay AD; Guo L; McDonald IA; Turner CI; Zhou W; Jarolimek W
    J Pharmacol Exp Ther; 2013 Nov; 347(2):365-74. PubMed ID: 23943052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
    Carpéné C; Bizou M; Tréguer K; Hasnaoui M; Grès S
    J Physiol Biochem; 2015 Sep; 71(3):487-96. PubMed ID: 25572340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases.
    Mészáros Z; Csányi A; Vallus G; Szombathy T; Karádi I; Magyar K
    Neurobiology (Bp); 2000; 8(2):215-23. PubMed ID: 11061216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
    Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
    Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An autoradiographic method of visualising semicarbazide-sensitive amine oxidase activity in mouse tissue sections.
    Grönvall JL; Garpenstrand H; Oreland L; Ekblom J
    Neurobiology (Bp); 2000; 8(2):167-77. PubMed ID: 11061213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes.
    Bour S; Daviaud D; Gres S; Lefort C; Prévot D; Zorzano A; Wabitsch M; Saulnier-Blache JS; Valet P; Carpéné C
    Biochimie; 2007 Aug; 89(8):916-25. PubMed ID: 17400359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic polyamines as potential amine oxidase inhibitors: a preliminary study.
    Emanuela B; Minarini A; Tumiatti V; Milelli A; Lunelli M; Pegoraro M; Rizzoli V; Di Paolo ML
    Amino Acids; 2012 Feb; 42(2-3):913-28. PubMed ID: 21858471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity.
    Martin MW; Newcomb J; Nunes JJ; Boucher C; Chai L; Epstein LF; Faust T; Flores S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Kim JL; Middleton S; Morgenstern K; Oliveira-dos-Santos A; Patel VF; Powers D; Rose P; Tudor Y; Turci SM; Welcher AA; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Ermann M; Johnston D; Saluste CG
    J Med Chem; 2008 Mar; 51(6):1637-48. PubMed ID: 18278858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.